Product Report - The HairMax LaserComb
Dr. Nelson Ferreira of
Sure Hair International
Created on January 28, 2008

Another reason why hair transplant patients are talking about Dr. Nelson Ferreira of Sure Hair International
Dr. Nelson Ferreira of
Sure Hair International
Created on January 3, 2008

"The Pill" and Hair Loss
Dr. Robert Jones of
Hair Transplant Center
Created on August 8, 2007

The most common cause of Baldness - Male Pattern Baldness (MPB)
Dr. Robert Jones of
Hair Transplant Center
Created on July 30, 2007

Cosmetic Options to Camaflage Hair Loss
Dr. Robert Jones of
Hair Transplant Center
Created on July 29, 2007

Finasteride - It's use for hair loss
Dr. Robert Jones of
Hair Transplant Center
Created on July 13, 2007

Eyelash and Eyebrow Transplants
Dr. Robert Jones of
Hair Transplant Center
Created on July 13, 2007

Follicular Unit Transplantation (FUT) and Follicular Unit Extraction (FUE)
Dr. Robert Jones of
Hair Transplant Center
Created on June 11, 2007

The Growth Cycle of Hair
Dr. Robert Jones of
Hair Transplant Center
Created on June 6, 2007

Minoxidil – medical treatment of hairloss
Dr. Robert Jones of
Hair Transplant Center
Created on June 5, 2007

Hair Transplant Repair Cases
Dr. Robert Jones of
Hair Transplant Center
Created on June 4, 2007

LaserComb Clinical Studies
Dr. Glenn Charles of
Charles Medical Group
Created on May 21, 2007

Trichophytic Closure: A New Method to close the Donor Site when performing Hair Transplantation
Dr. Robert Jones of
Hair Transplant Center
Created on May 16, 2007

Women's hair loss
Dr. Robert Jones of
Hair Transplant Center
Created on May 14, 2007

My Hair Transplant Experience, by Dr. Robert Jones
Dr. Robert Jones of
Hair Transplant Center
Created on May 11, 2007

read more articles...

Product Report - The HairMax LaserComb

Dr. Nelson Ferreira

Now there is well-founded hope in the battle to maintain a healthy head of hair: the HairMax LaserComb^TM. The LaserComb is a Laser Photo Therapy device that has been shown to be safe and effective for the home treatment of hair loss (Alopecia). Laser Photo Therapy, also called Low Level Laser Therapy in the medical community, is a safe, effective therapy with no known side effects.

Health Canada & FDA clears the HairMax LaserComb for hair growth

In December of 2002, the Canadian Government (Health Canada) cleared the HairMax LaserComb as a Class 2 Medical Device capable of stopping hair loss and re-growing hair in both men and women.

Now on sale for $545.00

About the HairMax LaserComb

The HairMax LaserComb is a hand-held, precision-built device that delivers the stimulating effects of laser energy to activate the growth of healthy, vibrant hair.

The HairMax LaserComb has continuously shown, in most people, to:

Control hair loss in men and women of all ages.
Stimulate re-growth of scalp hair.
Strengthen, improve and thicken existing hair.
Improve the condition, quality and overall cosmetic appearance of hair.

The HairMax LaserComb works by delivering the energizing effects of Laser Photo Therapy, a form of light stimulation, which causes hair to grow thicker, fuller and healthier. HairMax LaserComb treatments stimulate hair follicles to produce healthy new hair without topical solutions or drugs, which may cause worrisome changes in hormone levels.

In December of 2003, The LaserComb^TM was classified as a Class 2a Medical Device and The LaserComb was found to comply with quality, safety and performance requirements set forht by the Health Sciences Authority for medical devices.

For more information on how the HairMax LaserComb
can help treat your thinning hair, contact
Sure Hair International @ 1.877.444.7873 (416) 747.7873
Or visit a local office for a free demonstration and scalp analysis.

View Dr. Ferreira's profile and Sure Hair International's clinic locations

All articles provided by Dr. Nelson Ferreira

Product Report - The HairMax LaserComb
Article created on January 28, 2008
Another reason why hair transplant patients are talking about Dr. Nelson Ferreira of Sure Hair International
Article created on January 3, 2008